Drug Profile
Research programme: skeletal muscle activators - Cytokinetics
Alternative Names: CK 3672889; CK-1909178; CK-2066260Latest Information Update: 26 Apr 2023
Price :
$50
*
At a glance
- Originator Cytokinetics
- Developer Astellas Pharma; Cytokinetics
- Class Small molecules
- Mechanism of Action Troponin tropomyosin complex stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Muscle fatigue